MedPath

Pattern of prescription in cases witn epilepsy

Not yet recruiting
Conditions
Epilepsy, unspecified,
Registration Number
CTRI/2023/05/052888
Brief Summary

This is an observational study of prescription pattern of antiepileptic drugs at sms medical college and hospital, jaipur. The outcome measures will be to evaluate the drug prescribing pattern of antiepileptic drugs as per WHO core prescription indicators, average number of drugs per encounter, percentage of drugs prescribed by generic names, percentage of encounters with an injection prescribed, percentage of drugs prescribed from essential drug list, to estimate the proportion of cases where drugs were prescribed according to standard treatment guidelines.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
384
Inclusion Criteria

Patients of either sex who came in Neurology OPD, diagnosed with any type of epilepsy with age more than or equal to 18 years.

Exclusion Criteria
  • Patient or relative of cases not willing to sign informed consent form.
  • Patients with incomplete information.
  • Pregnant and lactating women.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) To evaluate the drug prescribing pattern of antiepileptic drugs as per WHO core prescription indicators:-6 months
a. Average number of drugs per encounter.6 months
c. Percentage of encounters with an injection prescribed. d. Percentage of drugs prescribed from essential drug list.6 months
b. Percentage of drugs prescribed by generic names.6 months
2) To estimate the proportion of cases where drugs were prescribed according to standard treatment guidelines6 months
Secondary Outcome Measures
NameTimeMethod
1) 2) 3) 4)5) 6)

Trial Locations

Locations (1)

Sawai man singh medical college

🇮🇳

Jaipur, RAJASTHAN, India

Sawai man singh medical college
🇮🇳Jaipur, RAJASTHAN, India
Dr dilip ganwani
Principal investigator
9664316904
dilipganwani27@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.